Creative Biolabs specializes in TAM reprogramming via nanomedicines, utilizing targeted microRNA delivery and TME modulation. We quantify M2-to-M1 phenotypic shifts to evaluate antitumor immunity and identify nanotherapeutic candidates.
Learn More →Creative Biolabs provides a high-resolution window into the tumor microenvironment (TME) by transitioning from simple cell counting to sophisticated spatial mapping. Our service is designed to solve the "black box" of immune exclusion by identifying how macrophages physically interact with other cellular components to dictate the success of immunotherapies. By quantifying "nearest neighbor" metrics, we mathematically define whether immunosuppressive M2 macrophages are physically shielding tumor cells from effector CD8 T cells, a critical factor in identifying "cold" versus "hot" tumors.
Macrophage spatial phenotyping represents the cutting-edge study of macrophage distribution and functional interaction within the preserved architecture of the tissue. While classical polarization models, which categorize cells into a binary M1 or M2 state, provided a foundational baseline, modern immunology increasingly confirms that macrophage function is fundamentally dictated by their local "niche." These specialized niches ultimately determine whether a macrophage promotes aggressive tumor growth or facilitates an effective immune response. By integrating ultra-high plex proteomics and spatially resolved transcriptomics, this advanced approach identifies how macrophages orchestrate complex immune evasion through localized pathways.
To ensure the highest depth of biological insight, Creative Biolabs offers an integrated suite of spatial technologies tailored to the unique complexities of macrophage biology. Our offerings span from protein-level architecture to deep-dive spatial transcriptomics.
Utilizing advanced co-detection by indexing (CODEX) and signal amplification platforms, we enable the simultaneous detection of 100+ protein markers on a single tissue section. This allows for the mapping of exhaustive macrophage subsets alongside T cell states and tumor heterogeneity markers.
We provide high-throughput, multispectral imaging that eliminates auto-fluorescence and spectral overlap. This is ideal for clinical-grade validation of specific cell-to-cell interactions, such as the PD-1/PD-L1 axis within the macrophage-rich stroma.
By combining protein phenotyping with spatially resolved RNA sequencing, we allow you to correlate the physical location of a macrophage with its precise transcriptional signature.
Our proprietary analysis pipeline includes cell-type clustering, neighborhood analysis, and Voronoi diagram generation. We translate raw image data into statistical proofs of immune exclusion and recruitment patterns.
Accelerate Your Project with Our Advanced Multiomics Platforms – Inquire About Our Custom Panel Capabilities
Creative Biolabs employs a streamlined and highly collaborative workflow designed to maximize the scientific value of every tissue sample.
This study investigates macrophage heterogeneity in diffuse large B-cell lymphoma (DLBCL) using spatially resolved transcriptomics. By applying digital spatial profiling to reactive and malignant lymphoid tissues, the authors identify distinct macrophage subtypes and generate six spatially derived gene signatures. These signatures reveal functional diversity beyond the traditional M1/M2 paradigm and demonstrate strong associations with DLBCL subtypes and patient survival. Overall, the work provides a comprehensive atlas of macrophage spatial biology with important prognostic and therapeutic implications.
Fig.1 Divergent transcriptomic profiles of macrophages in reactive versus malignant lymphoid tissues. 1
Creative Biolabs distinguishes itself as a premier partner by combining decades of deep-seated macrophage expertise with industry-leading spatial biology platforms. Our unique advantage lies in our comprehensive ability to interpret raw spatial data through the complex lens of macrophage plasticity and metabolic reprogramming. We do not simply provide raw coordinates; instead, we identify the specific "biological checkpoints" and cellular neighborhoods within your unique samples that drive experimental outcomes. By ensuring every project is overseen by senior immunologists who translate complex spatial metrics into actionable drug discovery leads, we help our partners navigate the intricacies of the tumor microenvironment with confidence and precision.
Experience the Creative Biolabs Advantage – Partner with Us to Secure Your Competitive Edge
Q1: How does spatial phenotyping differ from traditional IHC?
A1: Traditional IHC is limited to 1-2 markers per slide. Our spatial phenotyping detects up to 100+ markers simultaneously on a single section, allowing for the quantification of complex cellular neighborhoods and co-expression patterns.
Q2: Can you perform this service on archived FFPE samples?
A2: Yes, our workflows are highly optimized for FFPE samples. We utilize specialized antigen retrieval and signal amplification techniques to ensure reliable marker detection.
Q3: How do I know which technology is right for my project?
A3: We provide a free scientific consultation to help you choose between ultra-high plex protein mapping for architectural studies or spatial transcriptomics for deep pathway discovery.
To further your research, Creative Biolabs offers:
Creative Biolabs specializes in TAM reprogramming via nanomedicines, utilizing targeted microRNA delivery and TME modulation. We quantify M2-to-M1 phenotypic shifts to evaluate antitumor immunity and identify nanotherapeutic candidates.
Learn More →Creative Biolabs provides TAM depletion services, targeting CSF-1R and M2-specific apoptosis. We quantify M1/M2 ratios and lymphocyte-to-monocyte shifts to evaluate chemosensitivity and identify high-potency candidates for selective myeloid reduction.
Learn More →Creative Biolabs offers an industry-leading service that empowers researchers to move beyond cell density and into the realm of cellular interaction. Our multi-platform expertise and advanced bioinformatics ensure that you receive the most detailed map of the tumor microenvironment possible.
Contact Our Team for More Information and to Discuss Your Project – Submit Your Inquiry Online
Reference